Zentalis Pharmaceuticals (ZNTL) EPS (Basic) (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) recorded quarterly EPS (Basic) of -$0.5 in Q1 2026, down 2.04% quarter-over-quarter from -$0.49 in Q4 2025, and up 25.37% on a YoY basis from -$0.4 in Q1 2025.
Zentalis Pharmaceuticals (ZNTL) EPS (Basic) (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.5 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 25.37% year-over-year to -$0.5; the TTM figure through Mar 2026 stood at -$1.73 (up 44.73% YoY), while the FY2025 annual figure was -$1.91, up 18.03% from the prior year.
- EPS (Basic) was -$0.5 for Q1 2026 at Zentalis Pharmaceuticals, down from -$0.49 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.14 in Q1 2024 to a low of -$1.85 in Q2 2023.
- Historically, EPS (Basic) has averaged -$0.81 across 5 years, with a median of -$0.79 in 2023.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) sank 966.67% in 2022, then jumped 113.08% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.92 in 2022, then grew by 9.78% to -$0.83 in 2023, then rose by 20.48% to -$0.66 in 2024, then rose by 25.76% to -$0.49 in 2025, then retreated by 2.04% to -$0.5 in 2026.
- The last three EPS (Basic) figures came in at -$0.5 (Q1 2026), -$0.49 (Q4 2025), and -$0.37 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Zentalis Pharmaceuticals | 260.33 Mn | 260.33 Mn | - | -0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.50 |
| Dec 31, 2025 | -0.49 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.37 |
| Mar 31, 2025 | -0.67 |
| Dec 31, 2024 | -0.66 |
| Sep 30, 2024 | -0.56 |
| Jun 30, 2024 | -1.24 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | -0.83 |
| Sep 30, 2023 | -0.79 |
| Jun 30, 2023 | -1.85 |
| Mar 31, 2023 | -1.07 |
| Dec 31, 2022 | -0.92 |
| Sep 30, 2022 | -0.96 |
| Jun 30, 2022 | -1.34 |
| Mar 31, 2022 | -1.31 |
| Dec 31, 2021 | -1.11 |
| Sep 30, 2021 | -0.09 |
| Jun 30, 2021 | -1.34 |